Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Chinese FDA Shows Signs Of Loosening Up, Say Pharmaceutical Sector Leaders

This article was originally published in PharmAsia News

Executive Summary

SAN FRANCISCO - Roche will try to test a foreign-discovered drug in a first-in-man clinical trial in China in the next two years, according to one of the firm's top R&D officials in that country. The move would mark a huge shift in attitude at China's pharmaceutical regulatory agency, which to date only allows in-country discoveries to move into Chinese first-in-man clinical trials

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts